ID
32399
Descrição
This ODM file contains the form for documentation of any concomitant medication. To be assessed at screening and re-assessed at every visit. Study ID: 101999 Clinical Study ID: 101999 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran Study Indication: Migraine Disorders
Palavras-chave
Versões (2)
- 28/10/2018 28/10/2018 -
- 30/10/2018 30/10/2018 -
Titular dos direitos
GlaxoSmithKline
Transferido a
30 de outubro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Efficacy and Tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg) ID 101999
Concomitant Medication
- StudyEvent: ODM
Descrição
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descrição
MONITOR DATA VALIDATION CHECKS • Check that either ’Yes’ or ’No’ box at the top of the page has been completed. If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2347852
Descrição
List of Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descrição
MONITOR DATA VALIDATION CHECKS Ensure that the spelling of the Drug Name(s) is correct (use of Trade Names is preferred).
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2360065
Descrição
MONITOR DATA VALIDATION CHECKS • Ensure that the ’Reason for Medication’ is recorded on one of the following pages using the same terms: • Medical Conditions • Non-Serious Adverse Events • Serious Adverse Events Form
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2826696
Descrição
MONITOR DATA VALIDATION CHECKS • Check that either medication start date is completed or ’Taken Prior to Study?’ is ’Yes’. • It is acceptable for start date to be missing if ’Taken Prior to Study?’ is ’Yes’. • It is acceptable if ’Taken Prior to Study?’ is ’Yes’ and a start date is present, as long as the start date is prior to the date of the subject’s initial visit.
Tipo de dados
partialDate
Alias
- UMLS CUI [1]
- C2826734
Descrição
Taken Prior to Study?
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2826667
Descrição
MONITOR DATA VALIDATION CHECKS • Check that either medication stop date is completed or ’Ongoing Medication?’ is ’Yes’. • It is acceptable for stop date to be missing if ’Ongoing Medication?’ is ’Yes’.
Tipo de dados
partialDate
Alias
- UMLS CUI [1]
- C2826744
Descrição
Ongoing Medication
Tipo de dados
text
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medication
- StudyEvent: ODM
Sem comentários